Discovery and Pre-Clinical Characterization of Third-Generation 4-H Heteroaryldihydropyrimidine (HAP) Analogues as Hepatitis B Virus (HBV) Capsid Inhibitors

Zongxing Qiu(Roche (China)), Wei Zhu(Roche (China)), Guolong Wu(Roche (China)), Lu Gao(Naval University of Engineering), Xiao‐Jun Tian(Roche (China)), Buyu Kou(Roche (China)), Yue Fen Wang(Roche (China)), A. Mayweg(Institute of Medicinal Plant Development), Zhiheng Xu(Roche (China)), Yimin Hu(Roche (China)), Guang Yang(UNSW Sydney), Houguang Shi(Roche (China)), Mengwei Huang(Roche (China)), Buelent Koçer(Roche (China)), Sheng Zhong(University of Illinois Urbana-Champaign), Giorgio Ottaviani(Roche (China)), Zheng Zhou(Central China Normal University), Liping Shi(First Affiliated Hospital Zhejiang University), Hong C. Shen(Southern Medical University), Mingwei Zhou(Roche (China)), Kai Sun(Roche (China)), John A. T. Young(Roche (Switzerland)), Lei Guo(Second Military Medical University), Taishan Hu(Roche (China)), Zhisen Zhang(Institute of Medicinal Plant Development), S. Frank Yan(University of Science and Technology of China), Guozhi Tang(National Institutes of Health), Jianxun Xie(Unknown), Shuang Ren(Tongji University), Haixia Liu(Roche (China)), Yi Zhang(Roche (China)), Yuxia Zhang(University of Kansas Medical Center), Weixing Zhang(Roche (China)), Xiaoyue Wu(National Institute of Environmental Health Sciences), Yuan Zhou(Chinese Academy of Sciences), Yi Mao(Roche (China)), Hong-Xia Qiu(Roche (China)), Xue Zhou(Roche (China)), Jim Zhen Wu, Fang Shen(Roche (China)), Na Qin(Tianjin University of Technology), Lina Zhu(Tianjin University of Technology), Xianfeng Lin(Sir Run Run Shaw Hospital)
Journal of Medicinal Chemistry
March 25, 2017
Cited by 59


Related Papers